Tuesday, 22 December 2015
Label-free real-time plasmonic sensing allows quantification of alternatively spliced mRNA isoforms
Deregulated alternative splicing patterns could be considered as a hallmark of cancer. A recent paper in Biosensors and Bioelectronics reports a simple and robust technology using a Surface Plasmon Resonance (SPR) biosensor for label-free monitoring of alternative splicing events in real-time. The work was led by the ICN2 Nanobiosensors and Bioanalytical Applications Group in collaboration with the CRG.
